Cytokinetics Cash Flow Statement
NASDAQ: CYTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
62.91+0.90 (+1.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Cytokinetics free cash flow
In fiscal 2025, Cytokinetics generated -$510.0 million of operating cash flow and spent $24.8 million on capital expenditures. That left free cash flow of -$534.8 million, a free-cash-flow margin of -607.5% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Cytokinetics cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -784.96M | -589.53M | -526.24M | -388.95M | -215.31M | -127.29M | -121.69M | -106.29M | -127.79M | 16.45M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | -876.70% | — |
| Depreciation & Amortization | 10.13M | 9.53M | 11.89M | 5.81M | 2.28M | 1.83M | 1.29M | 1.24M | 1.92M | 741.00K |
| Stock-Based Compensation | 112.29M | 97.84M | 72.06M | 47.85M | 26.83M | 17.62M | 10.76M | 9.76M | 9.03M | 7.15M |
| Change in Working Capital | -18.54M | 44.26M | 14.08M | -22.37M | -38.66M | 2.59M | -4.57M | -21.61M | -1.03M | 12.13M |
| Operating Cash Flow | -510.01M | -395.89M | -414.33M | -299.52M | -142.52M | 8.94M | -90.91M | -101.22M | -101.76M | 36.98M |
| Capital Expenditures | -24.81M | -3.91M | -1.42M | -11.34M | -48.87M | -11.05M | -2.62M | -889.00K | -2.88M | -1.60M |
| Investing Cash Flow | 16.67M | -553.10M | 239.25M | -262.13M | -147.78M | -196.51M | -74.71M | 5.13M | -65.83M | -52.08M |
| Debt Issued | — | — | — | — | 0 | 0 | 1.71M | 9.90M | 1.26M | 15.00M |
| Debt Repaid | -10.81M | -8.68M | 0 | -47.65M | 0 | 0 | — | — | — | — |
| Financing Cash Flow | 524.46M | 930.61M | 221.32M | 516.17M | 319.98M | 234.12M | 159.79M | 13.13M | 225.92M | 16.89M |
| Net Change in Cash | 30.40M | -18.17M | 46.22M | -45.48M | 29.68M | 46.55M | -5.82M | -82.95M | 58.33M | 1.80M |
| Free Cash Flow | -534.82M | -399.80M | -415.75M | -310.85M | -191.39M | -2.11M | -93.53M | -102.10M | -104.64M | 35.39M |
This table shows 10 annual periods of Cytokinetics's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow CYTK's reporting calendar. What is a cash flow statement?